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Abstract
Background
Inappropriate antibiotic prescribing causes widespread serious health problems. To reduce
prescribing of antibiotics in Chinese primary care to children with upper respiratory tract
infections (URTIs), we developed an intervention comprising clinical guidelines, monthly
prescribing review meetings, doctor–patient communication skills training, and education
materials for caregivers. We previously evaluated our intervention using an unblinded clus-
ter-randomised controlled trial (cRCT) in 25 primary care facilities across two rural counties.
When our trial ended at the 6-month follow-up period, we found that the intervention had
reduced antibiotic prescribing for childhood URTIs by 29 percentage points (pp) (95% CI
−42 to −16).
Methods and findings
In this long-term follow-up study, we collected our trial outcomes from the one county (14
facilities and 1:1 cluster randomisation ratio) that had electronic records available 12 months
after the trial ended, at the 18-month follow-up period. Our primary outcome was the antibi-
otic prescription rate (APR)—the percentage of outpatient prescriptions containing any anti-
biotic(s) for children aged 2 to 14 years who had a primary diagnosis of a URTI and had no
other illness requiring antibiotics. We also conducted 15 in-depth interviews to understand
how interventions were sustained.
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In intervention facilities, the APR was 84% (1,171 out of 1,400) at baseline, 37% (515 out
of 1,380) at 6 months, and 54% (2,748 out of 5,084) at 18 months, and in control facilities, it
was 76% (1,063 out of 1,400), 77% (1,084 out of 1,400), and 75% (2,772 out of 3,685),
respectively. After adjusting for patient and prescribing doctor covariates, compared to the
baseline intervention-control difference, the difference at 6 months represented a 6-month
intervention-arm reduction in the APR of −49 pp (95% CI −63 to −35; P < 0.0001), and com-
pared to the baseline difference, the difference at 18 months represented an 18-month inter-
vention-arm reduction in the APR of −36 pp (95% CI −55 to −17; P < 0.0001). Compared to
the 6-month intervention-control difference, the difference at 18 months represented no
change in the APR: 13 pp (95% CI −7 to 33; P = 0.21). Factors reported to sustain reduc-
tions in antibiotic prescribing included doctors’ improved knowledge and communication
skills and focused prescription review meetings, whereas lack of supervision and monitoring
may be associated with relapse. Key limitations were not including all clusters from the trial
and not collecting returned visits or sepsis cases.
Conclusions
Our intervention was associated with sustained and substantial reductions in antibiotic pre-
scribing at the end of the intervention period and 12 months later. Our intervention may be
adapted to similar resource-poor settings.
Trial registration
ISRCTN registry ISRCTN14340536.
Author summary
Why was this study done?
• Antibiotic resistance is a global threat to health and effective healthcare, and a major
driver of antibiotic resistance is inappropriate prescribing of antibiotics.
• In low- and middle-income countries (LMICs) such as China, huge amounts of antibi-
otics are inappropriately prescribed to children in primary care for upper respiratory
tract infections (URTIs), such as common colds.
• However, very little evidence exists about what kinds of interventions can effectively
reduce this kind of inappropriate prescribing in China and other LMICs.
What did the researchers do and find?
• We developed an intervention that (1) trained rural Chinese primary care doctors to
appropriately prescribe antibiotics for childhood URTIs and to better explain to
patients/caregivers why they do not need antibiotics (when they do not), (2) made doc-
tors regularly review their own and their colleagues’ antibiotic prescribing practices and
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provided feedback to improve appropriate prescribing, and (3) provided educational
materials to patients/caregivers.
• We originally tested the intervention in 12 facilities compared to 13 facilities without
the intervention and found that, after 6 months, our intervention reduced inappropriate
prescribing of antibiotics for childhood URTIs by 29 percentage points (pp).
• In this study, we looked at what happened 12 months after the trial ended (and interven-
tion facilities were not obliged to continue the intervention) in seven intervention facili-
ties compared to seven nonintervention facilities and found that antibiotic prescribing
for childhood URTIs was still 36 pp lower in the intervention facilities.
What do these findings mean?
• Interventions that train and educate doctors and patients/caregivers about appropriate
prescribing as well as forcing doctors to review their and their colleagues’ prescribing
practices can substantially reduce inappropriate antibiotic prescribing over long
timescales.
• We would recommend that practices be put in place to regularly refresh doctors’ train-
ing and ensure that prescribing reviews are maintained to avoid the effects of such inter-
ventions declining over time.
• This kind of intervention needs to be adapted and tested in other LMICs across a wide
range of healthcare levels to combat antimicrobial resistance.
Introduction
Preventing the development of antimicrobial resistance is a global policy priority. Overuse of
antibiotics directly promotes development of antimicrobial resistance [1]. The largest cause of
inappropriate antibiotic use comes from treating respiratory infections, which are also the
most common reason for primary care consultations [2]. This challenge is most pressing in
low- and middle-income countries (LMICs), where commonly 80% of upper respiratory tract
infections (UTRIs), which are mostly viral, are inappropriately treated with antibiotics [3]
compared to around 20% of URTIs in high-income countries (HICs) [4]. Interventions aimed
at both clinicians and patients/caregivers have been shown to be more effective than those
aimed at only one group [5]. Only 16 randomised trials trying to reduce inappropriate antibi-
otic prescribing for URTIs have been conducted worldwide, and most in LMICs had limita-
tions in trial design and assessment. The duration of two well-designed trials in LMICs were
shorter (14 days [6] and 6 months [7]) than those in HICs (generally 12 months) [8–10]. The
effect sizes achieved were around a 25 percentage point (pp) reduction in antibiotic prescrib-
ing in LMICs [6,7] compared to around 10 pp in HICs [8–10], mainly because the baseline
level of antibiotic prescribing was much higher in LMICs. Studies examining the sustained
effects of trial interventions are rare: only two were conducted in HICs and reported sustained
trial intervention effects [11,12]. In LMICs, primary care doctors are poorly trained, receive
much lower pay, and see substantially more patients per day compared with their peers in
HICs [13], while antimicrobial stewardship is weak [14]. Sustained evidence on interventions
that work for a long term in these settings is urgently needed.
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Our cluster-randomised trial was done in 25 primary care facilities known as township hos-
pitals (with township-level divisions being the basic administrative or political divisions in
rural China, typically having a population between 50,000–150,000) across two counties in
rural China. It produced a 29 pp reduction in the antibiotic prescription rate (APR) among
children aged 2 to 14 years old with URTIs within 6 months [7]. Our intervention targeted
both doctors and caregivers. In the first month, we conducted training to improve township
doctors’ knowledge on antibiotic prescribing using concise clinical guidelines. Doctors were
also trained to improve their communication skills and give short educational messages to
caregivers during consultations, and monthly prescribing peer-review meetings were set up.
Caregivers received leaflets and watched videos on appropriate antibiotic use in waiting
rooms. The intervention was designed to be self-sustaining, e.g., prescription peer reviews
were first conducted with the trial team and then by each facility during their routine monthly
clinician meetings. This embedded approach is believed to improve acceptability and sustain-
ability of interventions to change clinical practice [15]; however, the long-term effect is
unknown. Here, we report our trial outcomes for one county in which electronic records were
available, 18 months after the start of the intervention or 12 months after the original follow-
up, to evaluate whether our multifaceted intervention produced sustained outcomes in reduc-
ing antibiotic prescribing for childhood UTRIs in rural China.
Methods
Our study is reported here as per the CONSORT extension (S1 CONSORT Checklist) for clus-
ter trial guidelines [16], with the abstract reported as per the CONSORT guidelines for report-
ing randomised trials in journal and conference abstracts [17]. We obtained ethical approval
from the University of Leeds School of Medicine Research Ethics Committee (MREC15-016),
the Guangxi Institute Review Boards at the Guangxi Autonomous Region Centre for Disease
Control and Prevention (CDC) (GXIRB2014-0036), and Shandong University (20151102) for
the trial and follow-up study.
Study design and participants
Our trial protocol and report describe the details of our trial design, intervention, and out-
comes [7,18]. In summary, our trial was a pragmatic, two-arm, cluster-randomised controlled
trial (cRCT) that aimed to reduce inappropriate prescribing of antibiotics for URTIs in chil-
dren aged 2 to 14 years old presenting as outpatients to township hospitals in rural Guangxi,
China. We used a cluster design because it was not possible to deliver the intervention at an
individual level. We recruited 25 township hospitals, 14 from Rong county and 11 from Liu-
jiang county, and randomised them all at the same time—stratified by county—using a com-
puter programme in a 1:1 (intervention to control) ratio in Rong county and a 5:6 ratio in
Liujiang county. Only the two facilities located in the county centres were ineligible. We did
not originally plan to collect post-trial outcomes but decided to conduct a long-term follow-up
after randomisation. However, because only Rong county had electronic prescription records
available, due to logistical limitations, we restricted this follow-up study to Rong county, and
all subsequent methods relate to this county alone. Within Rong county, we randomly selected
six internal pilot facilities (three intervention and three control) from the 14 already recruited
and randomised. We implemented the interventions in the three internal pilot intervention
facilities for a 6-month period between July and December 2015 and, in the remaining four
intervention facilities, between October 2015 and March 2016. After trial completion, we fol-
lowed up each of the 14 facilities for 12 months between January 2016 and March 2017.
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Outcomes
Although we did not publish our planned outcomes for this long-term follow-up study via a
protocol, we used the same outcomes that we used in our trial. Our primary outcome is the
APR—the percentage of prescriptions given to 2- to 14-year-old outpatients for URTIs that
contain any antibiotic(s). Our secondary antibiotic prescribing outcomes relate only to those
prescriptions including antibiotic(s), and were the percentage of antibiotic-containing pre-
scriptions that included (1) more than one antibiotic, (2) any broad-spectrum antibiotic(s),
and (3) any intravenously administered antibiotic(s). These outcomes can therefore reflect
changes in the proportion of specific types of antibiotics prescribed, as distinct from changes
in the overall proportion of prescriptions containing antibiotics. Additional secondary pre-
scribing outcomes and cost outcomes, which relate to all child URTI prescriptions, were the
percentage of prescriptions containing any (4) antivirals, (5) glucocorticoids, (6) vitamins, (7)
traditional Chinese medicines, and (8) any other nonantibiotic medicine(s); and (9) the full
prescription cost (including the total of any consultation costs, treatment costs, and medica-
tion costs), (10) the cost of all antibiotic medications, and (11) the cost of all nonantibiotic
medications. We measured all outcomes at baseline, 6-month follow-up (trial endline), and
18-month follow-up. In our trial, we added outcomes 3, 4, 5, 6, 7, 8, 10, and 11 post protocol,
and a protocol-planned secondary outcome of the quinolone prescription rate was too rare in
children for meaningful analysis and was excluded.
Procedures
We ended trial activities 6 months after implementation, with the trial team stopping any
direct interventions including organised training sessions or supervisory activities to monitor
antibiotic prescribing. However, the intervention clusters adopted the antimicrobial steward-
ship programme into routine practice, which included referring to our guidelines for clinical
knowledge and communication skills regarding respiratory disease, conducting peer reviews
of antibiotic prescribing on a regular basis in existing team meetings, and providing concise
education to patients on antibiotic use. Control clusters continued receiving usual care, in
which antibiotics were given at the individual clinician’s discretion, with no peer reviews for
antibiotic prescribing or caregiver education. We could not blind doctors or caregivers to
treatment allocation.
Data collection
We obtained all outcome data from electronic medical records of prescriptions issued by the
14 facilities in Rong county. Eligible prescriptions were those from children between 2 and 14
years old who had a primary diagnosis of a URTI as defined according to the International
Classification of Diseases 10th Revision [19]. We excluded any child who had a secondary
diagnosis of lower respiratory tract infections (such as pneumonia), who had a diagnosis of
acute otitis media (for which antibiotics would be appropriate), or who had any severe and/or
chronic disease requiring long-term antibiotic treatment or prophylaxis (S1 Table). For our
analyses, we collected eligible outpatient prescriptions at baseline (during the 3 months prior
to the start of the 6-month intervention period), at the 6-month trial endline (during the final
3 months of the 6-month intervention period), and at 18-month follow-up (during the final 3
months of the 18-month period since the intervention was first implemented). Based on the
trial protocol and analysis plan, we then randomly selected 200 eligible prescriptions from
each arm at baseline and 6 months and included all eligible prescriptions at 18 months for this
study.
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We conducted a qualitative study in three purposively selected township hospitals: two in
the intervention arm (one better performing and one less well performing in the trial based on
APR reductions) and one in the control arm. We did in-depth interviews with three township
hospital directors (one in each hospital), six doctors (two in each hospital), and six caregivers
of children (two in each hospital). We conducted interviews face to face by audio recording
and by taking notes. We used a semistructured interview guide covering key areas of interests
but retained the flexibility to accommodate unanticipated topics raised by participants. Our
interviews covered (1) doctors’ views on intervention components and any persistent change,
(2) doctors’ views on consultations with URTI patients and use of antibiotics, (3) caregivers’
knowledge and beliefs about antibiotics and any nonprescribed use, and (4) any contextual fac-
tors that affected antibiotic use (see S1 Text for interview guides). We obtained written (or ver-
bal for illiterate caregivers) informed consent from all participants.
Statistical analysis
Our trial’s sample size is detailed in our trial paper [7]. For this long-term follow-up study,
because we were using only electronic records, we also included all available eligible prescrip-
tions issued during the 12-month follow-up period across the facilities in Rong county in addi-
tion to using all previously analysed prescriptions. We did not publish our planned analyses
for this long-term follow-up study via a protocol. However, in this study, we analysed the same
outcomes and adjusted for the same covariates (apart from county given that we only used
data from one county) in our adjusted analyses as used in our trial. We also based our infer-
ences in this study on our adjusted results as in our trial (and, as in our trial, we also present
covariate-unadjusted results for comparison). Compared to our trial, we had to use different
methods of analysis in this study to allow us to estimate treatment effects between the different
time points. However, in this study (as with our trial), we based our inferences on the same
type of treatment effects (absolute differences between treatment arms for both binary and
continuous outcomes).
We calculated treatment effects using generalised estimating equations (GEEs), accounting
for clustering within facilities, and between time periods within facilities, via an exchangeable
correlation matrix. Where the models did not converge, we employed an identity correlation
matrix, given that GEEs are robust to misspecification of the correlation matrix [20]. We used
time-by-treatment interactions in all models to estimate treatment effects as either (1) the dif-
ference between the intervention minus control difference at 6 months and the intervention
minus control difference at baseline, (2) the difference between the treatment difference at 18
months and the treatment difference at baseline, or (3) the difference between the treatment
difference at 18 months and the treatment difference at 6 months. This allowed us to under-
stand the treatment’s effect on outcomes from baseline to the end of the trial period, from
baseline to the end of the follow-up period, and from the end of trial-directed intervention
activities to the end of the follow-up period. We calculated absolute treatment effects for our
binary prescribing outcomes on the pp scale using GEEs with binomial errors and identity
links, which have been shown to produce robust estimates of absolute treatment effects for
binary clustered data [21]. Where these models failed to converge as recommended, we next
tried GEEs with Poisson errors and identity links, and if they still failed, we used GEEs with
Gaussian errors and identity links, which have also been shown to produce robust absolute
treatment effects for binary clustered data [21]. For our cost outcomes, we used generalised
linear models (GLMs) with identity links and Gaussian errors to produce estimates of mean
differences [20]. We present covariate-adjusted results as our primary results because of the
potential for gains in power and precision, and following our trial analyses, we adjusted models
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for patients’ sex, age, and payment type (insured or fully out of pocket), as well as doctors’ sex,
age, and qualification level (based on 3 years of education or 5 years [MBBS equivalent]),
although we did not adjust for county given that, in this study, we only had data from one
county. Because diagnosis was not adjusted for in our original trial analyses but might be a
confounding factor, we also did a sensitivity analysis including diagnosis as an additional
covariate in the adjusted analysis of our primary outcome. We also calculated crude (unad-
justed for additional covariates) model results for comparison to our adjusted results. We did
not do any subgroup analyses because our trial paper subgroup analyses (looking at effect
modification by patient sex and payment type, as well as clinician sex, age, qualification level,
and years of experience) showed no evidence of subgroup differences in effectiveness [7]. As
with our trial analyses, we did not adjust the type 1 error rate for our secondary outcome anal-
yses and treat them as exploratory. There were no missing outcome data, but as with our trial
analyses, we excluded prescriptions with missing covariate data (<1%, see S3 Table) from the
adjusted analyses, which therefore assume that data are missing at random. As with our trial
analyses, there were no changes to the original treatment allocations of any clusters, and there-
fore the crude analyses that used all data were on an ‘intention-to-treat basis’, while the
adjusted analyses were on a ‘modified intention-to-treat’ basis due to the use of complete cases
only where covariate data were missing. We used Stata version 14 (Stata Corporation, College
Station, TX) for all analyses.
Qualitative analysis
We transcribed interviews verbatim in Standard Chinese. We employed thematic framework
analysis, with two researchers independently coding transcripts, indexing interview tran-
scripts, and charting indexes. Two researchers (ZZ and JY) independently coded transcripts,
indexed interview transcripts, and charted indexes. Any discrepancy was discussed and agreed
upon unanimously. Themes were discussed extensively and agreed upon within the research
team. The two bilingual researchers also translated the themes into English, and reviewed line
by line. Then, the themes were double checked by the principal investigator (XW) and the
qualitative study lead (RK). The analysis was guided by the theoretical domains framework
(TDF) that examines factors influencing different domains such as knowledge, skills, and
behaviour changes of providers and patients [18,22]. We categorised them into procedural,
interpersonal, and contextual factors. The research team discussed themes extensively before
agreeing on them. We used NVivo 10 (QSR International Pty Ltd.) for analysis.
Results
We followed up all 14 facilities (seven intervention and seven control) in Rong county at 6 and
18 months after the intervention was implemented. At baseline, out of 88,845 prescriptions
issued in the intervention arm, 6,112 (6.8%) were eligible for inclusion in the study, and in the
control arm, 3,523 out of 60,885 (5.4%) prescriptions were eligible. At 6 months in the inter-
vention arm, 5,094 out of 93,380 (5.5%) prescriptions were eligible, and in the control arm,
3,982 out of 65,233 (6.1%) prescriptions were eligible. At 18 months in the intervention arm,
5,084 out of 91,215 (5.6%) prescriptions were eligible, and in the control arm, 3,685 out of
69,939 (5.3%) prescriptions were eligible (Fig 1). We found that patient and doctor characters
were well balanced across the three periods with a modest (>10%) imbalance in payment
methods, doctor’s years of work, and diagnosis (acute pharyngitis and laryngitis) (Table 1).
Our primary outcome sensitivity analysis that included diagnosis as a covariate indicated no
substantive differences from the adjusted analysis excluding diagnosis (S4 Table), and so we
did not include diagnosis in any other analyses and only discuss the primary outcome results
Long-term outcomes following education on antibiotic prescribing in Chinese primary care
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Fig 1. CONSORT trial flow diagram. aWe excluded one township hospital located in the county centre because it is not closely comparable due to having
much better staff capacity and equipment than its peers and being close to the county general hospital. bBaseline prescriptions were prescribed during the 3
months prior to the start of the 6-month intervention period, 6-month trial endline prescriptions were prescribed during the final 3 months of the 6-month
intervention period, and the 18-month follow-up prescriptions were prescribed during the final 3 months of the 18-month period since the intervention was
first implemented. cTo evaluate the primary and secondary outcomes, we randomly selected 200 eligible prescriptions from each township hospital at both
Long-term outcomes following education on antibiotic prescribing in Chinese primary care
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from the main adjusted analysis. Additionally, for some covariate-adjusted analyses of pre-
scribing outcomes, the preferred GEEs failed to converge, and we had to use less preferred
forms of the GEEs (Table 2). However, for all crude analyses, the preferred GEEs converged,
and as the results differed little between the covariate-adjusted and crude analyses (S2 Table),
the covariate-adjusted results from the less preferred forms of the GEEs appear robust.
Antibiotic prescribing
Between baseline and 6 months, the raw overall APR reduced from 84% to 37% in the inter-
vention arm compared to no substantive change in the control arm (76% to 77%; Table 2).
Accounting for the baseline intervention-control difference, and after controlling for potential
confounders, there was a 6-month intervention-arm versus control-arm reduction in the APR
of −49 pp (95% CI −63 to −35; P< 0.0001). At 18 months, the APR was 54% in the interven-
tion arm and 75% in the control arm. Accounting for the treatment-arm difference at baseline,
there was a covariate-adjusted 18-month intervention-arm versus control-arm reduction in
the APR of −36 pp (95% CI −55 to −17; P< 0.0001). Accounting for the treatment-arm differ-
ence at 6 months and adjusting for covariates at 18 months, there was no intervention-arm
versus control-arm change in the APR: 13 pp (95% CI −7 to 33; P = 0.21). Intra-cluster correla-
tion coefficient estimates for the APR outcome are presented in S2 Table.
Fig 2 shows how the intervention-arm APR declined substantially following the interven-
tion, before plateauing and then appearing to gradually increase between 6 months and 18
months, although the statistical analysis showed no statistically significant change in the APR
between 6 and 18 months (Table 2). In the control arm, prescribing was constant throughout
at around 80%. Fig 3 shows that there were large variations in APR reductions in intervention
facilities at 6 months versus baseline (−74% to −13%) and at 18 months versus baseline (−65%
to −12%), compared to much smaller variations in control facilities (−10% to 10% at 6 months
versus baseline, and −6% to 10% at 18 months versus baseline). While the intervention effect
was sustained in most intervention facilities at 18 months, in one (facility 1) it increased, and
in two, it was substantially reduced (facility 5 and 6).
Secondary prescribing and cost outcomes
Compared to baseline intervention-control differences at 6-month follow-up, there was a
modest reduction in the broad-spectrum APR (−12 pp [95% CI −21 to −4]), a large reduction
in the cost of antibiotics per prescription (−0.35 US dollars [USD; 95% CI −0.45 to −0.25]),
and a modest increase in the cost of all other nonantibiotic medications per prescription (0.24
USD [95% CI 0.01–0.48]) (Table 2). Compared to baseline intervention-control differences at
18-month follow-up, there was a possible small reduction in the multiple APR (−6 pp [95% CI
−13 to 0]), a moderate reduction in the broad-spectrum APR (−20 pp [95% CI −34 to −6]),
and a large reduction in the cost of antibiotics (−0.26 [95% CI −0.38 to −0.13]). Compared to
differences at 6-month and 18-month follow-up, only the multiple APR showed any clear dif-
ference between treatment arms, with an additional—but small—possible reduction (−5 pp
[95% CI −8 to −1]) (Table 2). We also observed an overall high rate of prescribing for antivirals
(around 50%), glucocorticoids (around 20%), and traditional Chinese medicines (around
80%).
baseline and the 6-month trial endline, or all such prescriptions from township hospitals for which the total number available was less than 200. All eligible
prescriptions were included from the 18-month follow-up. In all analyses, prescriptions were analysed according to the treatment arm their township hospital
was originally allocated to. Clusters = township hospitals. CONSORT, Consolidated Standards of Reporting Trials; URTI, upper respiratory tract infection.
https://doi.org/10.1371/journal.pmed.1002733.g001
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Table 1. Patient and doctor characteristics at baseline, 6-month follow-up (trial endline), and 18-month follow-up.
Intervention Control
Baseline 6 months (trial
endline)
18 months Baseline 6 months (trial
endline)
18 months
No. clusters 7 7 7 7 7 7
Patients’ characteristics
No. of prescriptions 1,400 1,380 5,084 1,400 1,400 3,685
Sex
Male 827 (59%) 779 (56%) 2,962
(58%)
776 (55%) 817 (58%) 2,219
(60%)
Female 572 (41%) 601 (44%) 2,122
(42%)
624 (45%) 583 (42%) 1,466
(40%)
Missing 1 (<1%) 0 0 0 0 0
Age group
2–4 952 (68%) 891 (65%) 3,312
(65%)
884 (63%) 957 (68%) 2,263
(61%)
5–14 448 (32%) 489 (35%) 1,772
(35%)
516 (37%) 443 (32%) 1,422
(39%)
Diagnoses
J00 Acute nasopharyngitis (common cold) 51 (4%) 72 (5%) 414 (8%) 64 (5%) 87 (6%) 400 (11%)
J01 Acute sinusitis 19 (1%) 11 (1%) 175 (3%) 18 (1%) 17 (1%) 11 (<1%)
J02 Acute pharyngitis 465 (33%) 537 (39%) 1,109
(22%)
516 (37%) 522 (37%) 1,471
(40%)
J03 Acute tonsillitis 150 (11%) 121 (9%) 599 (12%) 110 (8%) 138 (10%) 401 (11%)
J04 Acute laryngitis and tracheitis 58 (4%) 0 537 (11%) 0 2 (<1%) 286 (8%)
J05 Acute obstructive laryngitis (croup) and epiglottitis 0 0 0 0 0 0
J06 Acute upper respiratory infections of multiple and
unspecified sites
657 (47%) 639 (46%) 2,250
(44%)
692 (49%) 634 (45%) 1,116
(30%)
Payment method
Insurance copayment 1,090
(78%)
970 (70%) 2,584
(51%)
1,013
(72%)
889 (64%) 1,127
(31%)
Fully out of pocket 310 (22%) 410 (30%) 2,500
(50%)
387 (28%) 511 (36%) 2,558
(69%)
No. of medicines prescribed 5.1 (±1.5) 4.8 (±1.3) 4.7 (±1.2) 4.6 (±1.4) 4.8 (±1.4) 4.8 (±1.4)
Doctor characteristics
No. of doctors 79 83 85 88 83 89
Sex
Male 50 (63%) 52 (63%) 53 (62%) 52 (59%) 49 (59%) 53 (60%)
Female 29 (37%) 30 (36%) 31 (37%) 35 (40%) 33 (40%) 35 (39%)
Missing 0 1 (1%) 1 (1%) 1 (1%) 1 (1%) 1 (1%)
Age group
�35 37 (47%) 37 (45%) 39 (46%) 31 (35%) 30 (37%) 31 (35%)
36–44 35 (44%) 38 (46%) 38 (45%) 41 (47%) 40 (48%) 41 (46%)
�45 7 (9%) 7 (8%) 7 (8%) 15 (17%) 12 (14%) 16 (18%)
Missing 0 1 (1%) 1 (1%) 1 (1%) 1 (1%) 1 (1%)
Qualification level
3 years medical education 59 (75%) 60 (72%) 61 (72%) 68 (77%) 65 (79%) 70 (79%)
MBBS (5 years) 20 (25%) 22 (27%) 23 (27%) 19 (22%) 17 (20%) 18 (20%)
Missing 0 1 (1%) 1 (1%) 1 (1%) 1 (1%) 1 (1%)
Years of work
�5 12 (15%) 13 (16%) 13 (15%) 23 (26%) 20 (24%) 24 (27%)
(Continued)
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Qualitative study
Doctors in the two selected intervention facilities reported better clinical knowledge in appro-
priate use of antibiotics and continued to refer to our intervention guidelines in their practice.
They reported enhanced communication skills with patients/caregivers, as well as increased
confidence in not giving antibiotics for common URTIs, e.g., one doctor reported, “Prescrip-
tion has to follow patient symptoms and diagnosis [as in the guidelines]. I tell patients [care-
givers] with common colds to have a rest without taking any medicines. If they do not trust
me, go to find another doctor” (p005; doctor, male, 25–34 years old). In the control facility,
doctors (not trained on the clinical guideline and communication skills) reported reasons or
excuses for giving antibiotics as stated at baseline [23], such as the difficulty in differentiating
between viral and bacterial infections or avoiding patient complaints. We found that peer-
review meetings continued in all the intervention facilities, but with variation. The better per-
forming facilities continued to organise monthly peer-review meetings that were led by senior
doctors, issued specific targets to limit antibiotic use (e.g., a maximum of 20% APR for outpa-
tients), evaluated individual doctors’ prescription histories, and imposed specific fines (e.g.,
0.08 USD per unqualified prescription). In the less well performing facility, peer-review meet-
ings were less frequent (once a quarter) and had less stringent targets (e.g., a maximum of 40%
APR for outpatients).
Township directors reported that the lack of further supervisory and monitoring activities
by health authorities around antibiotic prescribing had downgraded the importance of the
antimicrobial stewardship programme in their perceptions. Caregivers in the intervention
facilities reported having received warnings on antibiotic overuse during their consultations,
but facilities stopped playing the information videos in waiting rooms and ran out of leaflets.
A few patients from both arms reported receiving antibiotics from village doctors or obtaining
amoxicillin in private pharmacies without prescriptions (see themes and detailed quotations in
S5 Table and associated interview guides in S1 Text).
Discussion
To our knowledge, our study is the first to investigate the post-trial sustainability of an antimi-
crobial stewardship programme in a resource-poor setting. Our main finding is that our com-
prehensive intervention, which targeted doctors and caregivers, was associated with a
substantial reduction in antibiotic prescribing 18 months after implementation, or 12 months
after all trial-directed intervention activities stopped. At both 6 months (the trial endline) and
18 months (12 months after the trial-directed intervention period) compared to baseline, our
intervention achieved a clear reduction in antibiotic prescribing (in the one county for which
we had data) that was much higher than what has been reported in previous similar trials
(albeit in HIC settings) [8,10]. However, although there was no statistically significant change
Table 1. (Continued)
Intervention Control
Baseline 6 months (trial
endline)
18 months Baseline 6 months (trial
endline)
18 months
6–10 22 (28%) 22 (26%) 23 (27%) 18 (20%) 17 (20%) 18 (20%)
�11 44 (57%) 47 (57%) 48 (57%) 46 (53%) 45 (55%) 46 (52%)
Missing 0 1 (1%) 1 (1%) 1 (1%) 1 (1%) 1 (1%)
Data are n (%) or mean (±SD).
https://doi.org/10.1371/journal.pmed.1002733.t001
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Table 2. Covariate-adjusted intervention effects for outcomes at 6-month follow-up and 18-month follow-up.
Outcome Period Interventiona Controla Intervention-control difference at 6-/
18-month follow-up versus difference at
baseline (95% CI; P value)b
Intervention-control difference at 18-month
follow-up versus difference at 6 months
(95% CI; P value)b
APR☯
Baseline 1,171/1,400
(84%)
1,063/1,400
(76%)
6
months
515/1,380
(37%)
1,084/1,400
(77%)
−49 pp (−63 to −35); <0.0001
18
months
2,748/5,084
(54%)
2,772/3,685
(75%)
−36 pp (−55 to −17); <0.0001 13 pp (−7 to 33); 0.21
Multiple APR¶
Baseline 103/1,171 (9%) 83/1,063
(8%)
6
months
29/515 (6%) 65/1,084
(6%)
−2 pp (−7 to 3); 0.51
18
months
54/2,748 (2%) 209/2,772
(8%)
−6 pp (−13 to 0); 0.048 −5 pp (−8 to −1); 0.008
Broad-spectrum APR☯
Baseline 942/1,171
(80%)
787/1,063
(74%)
6
months
346/515 (67%) 794/1,084
(73%)
−12 pp (−21 to −4); 0.005
18
months
2,089/2,748
(76%)
2,082/2,772
(75%)
−20 pp (−34 to −6); 0.006 −8 pp (−22 to 6); 0.28
Infusion APR‡
Baseline 252/1,171
(22%)
244/1,063
(23%)
6
months
110/515 (21%) 331/1,084
(31%)
−8 pp (−23 to 7); 0.31
18
months
266/2,748
(10%)
365/2,772
(13%)
−2 pp (−15 to 11); 0.8 6 pp (−12 to 24); 0.5
Antiviral prescription
rate☯
Baseline 901/1,400
(64%)
609/1,400
(44%)
6
months
942/1,380
(68%)
732/1,400
(52%)
−3 pp (−18 to 11); 0.64
18
months
3,017/5,084
(59%)
1,778/3,685
(48%)
−3 pp (−29 to 24); 0.85 1 pp (−21 to 22); 0.93
Glucocorticoid
prescription rate¶
Baseline 326/1,400
(23%)
304/1,400
(22%)
6
months
298/1,380
(22%)
254/1,400
(18%)
2 pp (−11 to 14); 0.8
18
months
1,149/5,084
(23%)
585/3,685
(16%)
3 pp (−10 to 15); 0.69 1 pp (−11 to 13); 0.87
Vitamin prescription
rate☯
Baseline 192/1,400
(14%)
245/1,400
(18%)
6
months
166/1,380
(12%)
223/1,400
(16%)
0 pp (−7 to 7); 0.97
18
months
936/5,084
(18%)
700/3,685
(19%)
4 pp (−3 to 11); 0.24 4 pp (−5 to 13); 0.41
(Continued)
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Table 2. (Continued)
Outcome Period Interventiona Controla Intervention-control difference at 6-/
18-month follow-up versus difference at
baseline (95% CI; P value)b
Intervention-control difference at 18-month
follow-up versus difference at 6 months
(95% CI; P value)b
Traditional Chinese
medicine prescription
rate☯
Baseline 1,152/1,400
(82%)
999/1,400
(71%)
6
months
1,231/1,380
(89%)
1096/1,400
(78%)
−1 pp (−13 to 12); 0.92
18
months
4,501/5,084
(89%)
3,077/3,685
(84%)
−2 pp (−12 to 7); 0.66 −1 pp (−8 to 5); 0.66
Nonantibiotic medicine
prescription rate☯
Baseline 1,218/1,400
(87%)
1,194/1,400
(85%)
6
months
1,179/1,380
(85%)
1,215/1,400
(87%)
−2 pp (−8 to 4); 0.52
18
months
4,428/5,084
(87%)
3,255/3,685
(88%)
−6 pp (−16 to 3); 0.17 −4 pp (−10 to 1); 0.1
Full prescription cost
(USD)¶
Baseline 4.2 (±1.6) 4.4 (±1.9)
6
months
4.2 (±1.6) 4.4 (±2.0) −0.09 (−0.34 to 0.15); 0.46
18
months
4.5 (±2.2) 4.7 (±3.0) 0.02 (−0.41 to 0.45); 0.93 0.11 (−0.36 to 0.58); 0.64
Antibiotics cost (USD)¶
Baseline 0.6 (±0.4) 0.5 (±0.4)
6
months
0.3 (±0.4) 0.5 (±0.4) −0.35 (−0.45 to −0.25); <0.0001
18
months
0.4 (±0.4) 0.5 (±0.4) −0.26 (−0.38 to −0.13); <0.0001 0.09 (−0.05 to 0.23); 0.19
Other medication cost
(USD)¶
Baseline 2.2 (±1.5) 2.4 (±1.9)
6
months
2.5 (±1.5) 3.1 (±2.7) 0.24 (0.01 to 0.48); 0.043
18
months
2.7 (±2.1) 2.8 (±2.9) 0.24 (−0.16 to 0.64); 0.24 0.00 (−0.46 to 0.45); 0.99
aIntervention and control-arm summary data for prescribing rate outcomes are the number of prescriptions containing the relevant medicine divided by the total
number of prescriptions (percentage), and for cost outcomes are mean (±SD).
bEstimated treatment effects represent either the difference between the intervention minus control difference at 6 months and the intervention minus control
difference at baseline, or the difference between the treatment effect at 18 months and the treatment effect at baseline months, or they represent the difference between
the treatment effect at 18 months and the treatment effect at 6 months as indicated, after adjusting for patient sex, age, and insurance payment status, and prescribing
doctor sex, age, and education level.
Treatment effects for prescribing rate outcomes are on the absolute pp scale, and for cost outcomes are in USD per prescription, with each prescription representing one
patient–doctor consultation. The between-time-period difference in treatment-arm differences (and the associated 95% CIs and P values) are estimated by GEE
coefficients for the interaction between treatment arm and time period. The GEEs use either binomial errors and an identity link (☯, ‡) for binary prescribing outcomes,
or Gaussian errors and an identity link (¶) for continuous cost outcomes or those binary prescribing outcomes where the binomial and then Poisson identity models
failed to converge. GEEs accounted for clustering within facilities and within facilities across time periods either using an exchangeable correlation matrix (☯, ¶) or an
identity matrix (‡) where the GEEs failed to converge with an exchangeable correlation matrix, given that GEEs are robust to misspecification of the correlation matrix.
Outcome data were present for all outcomes and time periods, but <1% of covariate data were missing (see S3 Table). Analyses therefore excluded all patient
prescriptions with missing covariate data and assume that data are missing at random. There were no changes to the original allocation of facilities.
Abbreviations: APR, antibiotic prescription rate; GEE, generalised estimating equation; pp, percentage points; USD, US dollars.
https://doi.org/10.1371/journal.pmed.1002733.t002
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in antibiotic prescribing between 6 months and 18 months, we would not expect the improve-
ments to be fully sustained over this and longer time periods in the absence of any further
intervention-related inputs.
Looking only at those prescriptions where antibiotics were issued, we also observed a small
reduction in the relative prescribing rate for multiple antibiotics versus single antibiotics at 18
months compared to treatment-arm differences at baseline, and at 18 months compared to
treatment-arm differences at 6 months. Similarly, looking only at those prescriptions where
antibiotics were issued, we also observed a moderate reduction in the relative prescribing rate
for broad-spectrum antibiotics versus narrow-spectrum antibiotics at 6 months compared to
treatment-arm differences at baseline, and at 18 months compared to treatment-arm differ-
ences at baseline. However, these relative prescribing rate results for specific types of antibiot-
ics are at risk of bias (see limitations below) in comparison to the US, where a trial that used
doctor education reduced the overall rate of broad-spectrum antibiotic prescribing [24].
In interpreting our study’s findings, it should be noted that we only reported results from
the 14 facilities in one county (Rong), not from all 25 facilities in our trial, due to logistical con-
straints in obtaining the paper-based records from the other county (Liujiang). The interven-
tion achieved a larger reduction (point estimate) of APR at 6 months in Rong county alone
compared to when we analysed both counties’ 6-month data in our trial endline results paper
(−49 pp [95% CI −63 to −35] versus −29 pp [95% CI −42 to −16]). This indicated potential het-
erogeneity in effectiveness between counties, although the overlap in CIs indicates that this
conclusion must be treated cautiously.
Evidence from this long-term follow-up study shows that our intervention appears to have
changed doctors’ knowledge and attitudes [23] and led to long-term benefits in antibiotic
Fig 2. Township hospital monthly APRs (intervention and control arms) for children (2–14 years old) diagnosed with URTIs before, during, and after the
intervention period. Data points are monthly mean APRs calculated from cluster-level APR values. Error bars are 95% CIs. APR, antibiotic prescription rate; URTI,
upper respiratory tract infection.
https://doi.org/10.1371/journal.pmed.1002733.g002
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prescribing. This is surprising given the fact that improved knowledge among rural doctors
has often not led to the more rational use of antibiotics [25]. In addition, China’s health reform
policies, such as introducing the essential medicine list, a “Zero Mark-Up” policy for medica-
tions dispensed in hospital pharmacies, and a target cap of 20% for outpatient antibiotic pre-
scribing did not result in reduced APRs in primary care settings [26–28]. Our success in
behaviour change may have been achieved because the intervention was designed to be easily
embedded into routine practice in township hospitals. Doctors reported that they maintained
better knowledge in antibiotic use, improved communication skills with patients, and had the
confidence to not prescribe antibiotics despite caregivers’ requests. This echoes findings from
the Netherlands, where enhanced clinician communication skills were found to be the main
cause of sustained reductions in antibiotic prescribing [11]. Peer-review meetings seemed to
be another important contributing factor. In this study, the better performing facilities contin-
ued to conduct monthly peer-reviews strategies, such as prescribing targets, issuing specific
prescribing feedback, and small fines for doctors who overprescribed. These factors were also
highlighted in a qualitative systematic review [29] as key to changing doctors’ antibiotic pre-
scribing behaviours. Our antimicrobial stewardship programme has also been proved cost-
effective: implementation costs 391 USD per facility, and the incremental cost is 0.03 USD
per pp reduction in APR at 6 months [30]. We also observed a reduction of infusion antibiotics
in both arms, which may be due to the introduction of regulations to reduce infusions by the
County Health Bureau during our study period.
However, we believe that refresher training sessions and regular supervisory and monitor-
ing should be continued if the intervention effect is to be sustained beyond 18 months. Reduc-
tion in effect is common after behaviour change interventions. In a trial in Vietnam, though
Fig 3. Facility-level changes in the APR for childhood (2–14 years old) URTIs from baseline to 6- and 18-month follow-up. Dotted bars represent changes between
baseline and 6 months (trial endline), while solid bars represent changes between baseline and 18-month follow-up (12 months after trial endline). Facility numbers 2, 5
and 8 were included in the qualitative study. APR, antibiotic prescription rate; URTI, upper respiratory tract infection.
https://doi.org/10.1371/journal.pmed.1002733.g003
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antibiotic prescribing was reduced by 14 pp after C-reactive protein tests had been introduced
to rural primary care facilities, the positive effect ceased soon after the study because of patient
demands, incentives provided by pharmaceutical companies, and the pressure to replenish
pharmacy stocks in these facilities [14]. In our study, only two intervention facilities exhibited
a substantial reduction of intervention effect on the APR at 18 months, which may have been
caused by factors such as a change of hospital leadership, while all other intervention facilities
exhibited little change from 6 to 18 months.
Though we did not observe any clear increase in prescribing of other medications as a sub-
stitution effect for reducing antibiotic prescribing, the overall high prescribing rates for antivi-
rals, glucocorticoids, and traditional Chinese medicines were likely to be inappropriate. This
may be related to doctors’ lack of knowledge and/or the pressures of maintaining prescription
revenues (from health insurance and/or out-of-pocket revenue). Glucocorticoid steroids may
be beneficial to asthma but not to URTIs. Occasional use of antivirals such as oseltamivir may
be justified in high-risk children if symptoms suggest influenza. However, the generally high
rate of antiviral prescribing is likely to be inappropriate in children with URTIs [31]. Patient
preference and requests for symptom relief may lead to the very high prescription rate (80%)
of traditional Chinese medicines observed. Another possible explanation is that township hos-
pitals have financial incentives to prescribe traditional Chinese medicines because they are
exempt from the Zero Mark-up policy, and so they can add a 15% or more margin when dis-
pensed from hospital pharmacies. We also observed a reduction of infusion antibiotics in both
arms at 18 months, which may be due to the introduction of regulations to reduce infusions by
the County Health Bureau during our study period.
Our study has several limitations. First, we did not include all facilities from the original
trial, but only in one county for which there was a higher effect size than in the other county.
The overall effect may be less across the two counties and if scaled-up more widely. Second, we
did not collect actual antibiotic consumption. China has strengthened its antibiotic steward-
ship policy since 2012 to restrict antibiotic prescription to qualified physicians, while village
doctors are considered restricted practitioners who do not have the right to prescribe antibiot-
ics. In practice, we found gaps in enforcement, with some patients reporting obtaining antibi-
otics from village doctors or private pharmacies. Future interventions should include village
doctors, given that they act as the first contact for medical consultations in rural areas [25],
and utilise innovative ways to measure antibiotic consumption. Third, our secondary out-
comes measuring the prescribing rates of specific types of antibiotics were relative rates with
the denominator being all prescriptions containing one or more antibiotics. Because these are
outcomes were effectively measured for subgroups that were determined post randomisation
and were conditional on antibiotic prescription, there is a risk of bias/confounding, and these
results should therefore be treated cautiously. Fourth, we did not measure harms from the
trial, such as return visits or sepsis cases. However, doctor educational or shared decision-mak-
ing interventions have not previously increased severe bacterial infections or reconsultations
[32]. Fifth, the facilities in which we performed qualitative interviews were preselected based
on the trial results, restricting our ability to collect information regarding the reasons why two
facilities relapsed in prescribing rates during post-trial follow-up. Sixth, the study was con-
ducted in rural southwest China, where findings may not be easily generalisable to other low-
resource settings because health systems may be different. However, interventions in this
study targeted similar real-world challenges in other LMICs, including widespread inappropri-
ate use of antibiotics for URTIs, lack of knowledge on antimicrobial resistance among health
providers, lack of antimicrobial resistance stewardship programmes, and demands for antibi-
otics from patients.
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Conclusion
We found that, in one county of the trial sites, the benefits of our antimicrobial stewardship
programme on antibiotic prescribing were well maintained 18 months after implementation,
or 12 months after trial-led activities finished. This indicates that effects may be sustained for
interventions including evidence-based guidelines, peer-review meetings, improved doctor–
patient communications, and the provision of concise education to caregivers during consulta-
tions, in similar settings. However, although there was no statistically significant change in the
APR after trial activities ceased, it is of course expected that, without further intervention-
related inputs, the improvements in antibiotic prescribing would decline. This study implies
that this type of intervention may be successful in other LMICs with similar challenges.
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